glp-1 gastric stasis class action in louisiana lawmakers are considering a bill that would expand Medicaid access to drugs for obesity treatment, a move supporters say could improve health outcomes and reduce long-term costs. https://bit.ly/4usEGVI semaglutide gastric stasis class action

A., Gazis R., et al

The box is warm

The FDA warned seven companies to stop selling unapproved eye drops

Rapid weight loss is a recognised risk factor for gallstone formation

Halliwell & Gutteridge, 1984)

Of people on the medications, 45% say they eat more vegetables, 42% say they have smaller meals, 40% have more protein and 30% have more fiber. Florian Schattenmann, chief technology officer and vice president for innovation and research and development for Cargill, Minneapolis, sees consumer adoption of GLP-1s accelerating as oral applications become more available and as intellectual property protections run out and open the door for generic brands